☆ 4.7 Editorial Material

NfL as Analogue of C-Reactive Protein in Neurologic Diseases

NEUROLOGY (2022)

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Serum NFL discriminates Parkinson disease from essential tremor and reflect motor and cognition severity

Yixian Huang et al.

Summary: Serum neurofilament light chain (NFL) levels are significantly elevated in Parkinson disease (PD) patients and may serve as a useful clinical biomarker for discriminating PD patients from other diseases. Serum NFL may also serve as a potential blood biomarker for motor and cognition severity in PD.

BMC NEUROLOGY (2022)

Add to Collection
Editorial Material Pharmacology & Pharmacy

Blood-Based Alzheimer's Biomarkers

[Anonymous]

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection
Article Clinical Neurology

Association of Neurofilament Light With the Development and Severity of Parkinson Disease

Shannon Halloway et al.

Summary: This study found an association between serum NfL concentration and incident clinical PD, parkinsonian signs, and physical functioning decline in a population-based sample. The results suggest that NfL may serve as a potential biomarker for neurodegeneration, including PD outcomes.

NEUROLOGY (2022)

Add to Collection
Review Clinical Neurology

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation

Charlotte E. Teunissen et al.

Summary: Recent research suggests that blood-based biomarkers for Alzheimer's disease may become a reality, with consistent results across different cohorts. Additionally, other blood-based biomarkers can provide information about disease progression and treatment effects.

LANCET NEUROLOGY (2022)

Add to Collection
Review Neurosciences

Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain

Lorenzo Gaetani et al.

Summary: Identifying neurological diseases in their presymptomatic phase is crucial for future research. NfL, a biomarker, has shown promising results in detecting diseases early and understanding the pathophysiology.

FRONTIERS IN NEUROSCIENCE (2021)

Add to Collection
Review Neurosciences

Neurofilaments: The C-Reactive Protein of Neurology

Kate L. Lambertsen et al.

BRAIN SCIENCES (2020)

Add to Collection
Article Clinical Neurology

Serum NFL discriminates Parkinson disease from atypical parkinsonisms

Taina M. Marques et al.

NEUROLOGY (2019)

Add to Collection
Review Clinical Neurology

Neurofilament light chain as a biomarker in neurological disorders

Lorenzo Gaetani et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Add to Collection
Article Clinical Neurology

A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation

Lorenzo Gaetani et al.

ALZHEIMERS RESEARCH & THERAPY (2018)

Add to Collection
Review Clinical Neurology

Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of Protein-Misfolding Cyclic Amplification and Real-Time Quaking-Induced Conversion as Diagnostic Tools

Silvia Paciotti et al.

FRONTIERS IN NEUROLOGY (2018)

Add to Collection
Review Clinical Neurology

Characterizing Premotor Parkinson's Disease: Clinical Features and Objective Markers

Lama M. Chahine et al.

MOVEMENT DISORDERS CLINICAL PRACTICE (2014)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.